Translation

The Translational Index Score: Improving the Entire Drug Development Cycle

Jo Varshney, Ph.D., D.V.M.

Failing Fast

Maximizing Resources and Potential for Success by Failing Fast

Nazar Elkarim, Ph.D.

Mikart

Expanded CDMO Capabilities

On the Journey to Support Drug Developers With End-to-End Outsourcing

Michelle Hall

Mikart

Preclinical Data

Transforming Drug Development with Frictionless Access to Real-Time Preclinical Data

Mark Mintz; Kristen M. Eisenhauer

Charles River Laboratories

Global License Agreement

Hovione and JIXING Announce an Exclusive Global License Agreement for Ophthalmology Program

Hovione

Tissue Models

Developing a Robust In Vitro Intestinal Model for Preclinical Candidate Screening of GI Toxicity

Ron Laethem, Ph.D.

Altis Biosystems

Tissue Models

The Power of RepliGut In Vitro Intestinal Stem Cell Models

Bailey Zwarycz, Ph.D

Altis Biosystems

Preclinical

Increasing the Efficiency of Drug Development with Preclinical Testing Using Human Intestinal Stem Cells

Ron Laethem, Ph.D.

Altis Biosystems

Preclinical Data

Alligator Bioscience: New Preclinical Data Demonstrate Strong Anti-tumor Effects for the 4-1BB Antibody ATOR-1017

Nice Insight

Viral Vectors

Preclinical to Nearly Commercial Virus and Viral Vector Manufacturing

Jean Blehaut

Axplora

Advisory Board

Kymera Therapeutics Announces Expansion of Scientific Advisory Board to Advance Pre-Clinical Molecules Toward the Clinic

Kymera Therapeutics

Preclinical Data

Encouraging Preclinical Data for Anticancer Drugs Reported by Verseon

Cynthia A. Challener, Ph.D.

Pharma's Almanac

Preclinical Data

Syros Announces New Preclinical Data on SY-1365 Showing Potent Anti-Tumor Activity in Multiple Models of Heavily Pretreated Ovarian Cancer

Syros Pharmaceuticals

Preclinical Data

Tolero Pharmaceuticals to Present Preclinical Data Supporting Apoptosis-Inducing Activity of Alvocidib in Acute Myeloid Leukemia

Tolero Pharmaceuticals, Inc.

Acquisition

Frontage Acquires Concord Biosciences, Adding Preclinical, Agrochemical and Toxicology Services to the Existing Product Development Portfolio

Frontage

Gilead Announces Data from New Preclinical Study Evaluating a Combination of an Investigational TLR7 Agonist and an Investigational HIV Envelope

Gilead Sciences

Drug Discovery

Defense Department Commits $16 Million to Fight Bacterial Bioweapons

Steve Kuehn

Nice Insight

Increasing the Chances of Finding the Best Possible CRO/CMO Fit

Wei Gao

Nice Insight

Integrating Drug Discovery and Development to Improve Efficiency and Candidate Success

Cyrus K. Mirsaidi

Bioduro LLC

Bioreactor Preferences from an Outsourcing Perspective – Part I

KshitiJ (TJ) Ladage

Nice Insight